These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27326818)

  • 21. DPP-4 inhibitor and PPARγ agonist restore the loss of CA1 dendritic spines in obese insulin-resistant rats.
    Sripetchwandee J; Pipatpiboon N; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Arch Med Res; 2014 Oct; 45(7):547-52. PubMed ID: 25281415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart.
    Chinda K; Sanit J; Chattipakorn S; Chattipakorn N
    Diab Vasc Dis Res; 2014 Mar; 11(2):75-83. PubMed ID: 24357666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 Diabetes.
    Wu T; Trahair LG; Little TJ; Bound MJ; Zhang X; Wu H; Sun Z; Horowitz M; Rayner CK; Jones KL
    Diabetes Care; 2017 May; 40(5):702-705. PubMed ID: 28258090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury.
    Chinda K; Palee S; Surinkaew S; Phornphutkul M; Chattipakorn S; Chattipakorn N
    Int J Cardiol; 2013 Jul; 167(2):451-7. PubMed ID: 22285447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipeptidyl peptidase-4 inhibitors and the ischemic heart: Additional benefits beyond glycemic control.
    Chattipakorn N; Apaijai N; Chattipakorn SC
    Int J Cardiol; 2016 Jan; 202():415-6. PubMed ID: 26432493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone deprivation accelerates cardiac dysfunction in obese male rats.
    Pongkan W; Pintana H; Sivasinprasasn S; Jaiwongkam T; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2016 Jun; 229(3):209-20. PubMed ID: 27000685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone Deprivation Aggravates Left-Ventricular Dysfunction in Male Obese Insulin-Resistant Rats via Impairing Cardiac Mitochondrial Function and Dynamics Proteins.
    Apaiajai N; Chunchai T; Jaiwongkam T; Kerdphoo S; Chattipakorn SC; Chattipakorn N
    Gerontology; 2018; 64(4):333-343. PubMed ID: 29566382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats.
    Tunapong W; Apaijai N; Yasom S; Tanajak P; Wanchai K; Chunchai T; Kerdphoo S; Eaimworawuthikul S; Thiennimitr P; Pongchaidecha A; Lungkaphin A; Pratchayasakul W; Chattipakorn SC; Chattipakorn N
    Eur J Nutr; 2018 Sep; 57(6):2091-2104. PubMed ID: 28608320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen deprivation aggravates intracellular calcium dyshomeostasis in the heart of obese-insulin resistant rats.
    Palee S; Minta W; Mantor D; Sutham W; Kerdphoo S; Pratchayasakul W; Chattipakorn SC; Chattipakorn N
    J Cell Physiol; 2019 May; 234(5):6983-6991. PubMed ID: 30417357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions.
    Pratchayasakul W; Sa-Nguanmoo P; Sivasinprasasn S; Pintana H; Tawinvisan R; Sripetchwandee J; Kumfu S; Chattipakorn N; Chattipakorn SC
    Horm Behav; 2015 Jun; 72():68-77. PubMed ID: 25989597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus.
    Zografou I; Sampanis C; Gkaliagkousi E; Iliadis F; Papageorgiou A; Doukelis P; Vogiatzis K; Douma S
    Hormones (Athens); 2015; 14(1):118-25. PubMed ID: 25402372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats.
    Pintana H; Apaijai N; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Life Sci; 2012 Oct; 91(11-12):409-414. PubMed ID: 22925597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D3 potentiates the nephroprotective effects of vildagliptin-metformin combination in a rat model of metabolic syndrome.
    Wahba NS; Abdel-Ghany RH; Ghareib SA; Abdel-Aal M; Alsemeh AE; Sabry D
    Fundam Clin Pharmacol; 2022 Apr; 36(2):306-323. PubMed ID: 34453360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice.
    Marques AP; Cunha-Santos J; Leal H; Sousa-Ferreira L; Pereira de Almeida L; Cavadas C; Rosmaninho-Salgado J
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):403-413. PubMed ID: 29154902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The scientific evidence: vildagliptin and the benefits of islet enhancement.
    Mathieu C
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():9-17. PubMed ID: 19385979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial dynamic modulation exerts cardiometabolic protection in obese insulin-resistant rats.
    Maneechote C; Palee S; Apaijai N; Kerdphoo S; Jaiwongkam T; Chattipakorn SC; Chattipakorn N
    Clin Sci (Lond); 2019 Dec; 133(24):2431-2447. PubMed ID: 31808509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy with nateglinide and vildagliptin improves postprandial metabolic derangements in Zucker fatty rats.
    Miura K; Kitahara Y; Yamagishi S
    Horm Metab Res; 2010 Sep; 42(10):731-5. PubMed ID: 20625970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen restores brain insulin sensitivity in ovariectomized non-obese rats, but not in ovariectomized obese rats.
    Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Metabolism; 2014 Jun; 63(6):851-9. PubMed ID: 24742706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.
    Ahrén B; Pacini G; Tura A; Foley JE; Schweizer A
    Horm Metab Res; 2007 Nov; 39(11):826-9. PubMed ID: 17992639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats.
    Charoenphandhu N; Suntornsaratoon P; Sa-Nguanmoo P; Tanajak P; Teerapornpuntakit J; Aeimlapa R; Chattipakorn N; Chattipakorn S
    Can J Diabetes; 2018 Oct; 42(5):545-552. PubMed ID: 29606326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.